Intracranial Metastasis of Esthesioneuroblastoma May Occur 19 Years After Remission
Recurrence of esthesioneuroblastoma with non-contiguous intracranial metastasis is possible 19 years after remission, a review suggests.
Head and Neck Cancer News
HEAD AND NECK CANCER ADVISOR
Head and Neck Cancer News
MYC Inhibitor Can Stave Off Progression in Patients With Advanced Solid Tumors
In a first-in-human trial of patients with solid tumors, a MYC inhibitor appeared tolerable and enabled nearly half of evaluable patients to maintain stable disease.
Durvalumab Plus IMRT No Better Than Cetuximab Plus IMRT in Head and Neck Cancer
Durvalumab plus IMRT proved no more effective than cetuximab plus IMRT in patients with treatment-naïve, locoregionally advanced head and neck squamous cell carcinoma.
COVID-19 Vaccination Should Not Interrupt ICI Therapy, Researchers Say
COVID-19 vaccination is safe for cancer patients receiving immune checkpoint inhibitors and should not interrupt therapy, according to researchers.
Meta-Analysis Clarifies Risk of Cutaneous AEs Associated With PI3K Inhibitors
The incidence of cutaneous adverse events in cancer patients receiving PI3K inhibitors may be as high as 29%, a meta-analysis suggests.
Poor Outcomes Seen in Advanced Cancer Patients Treated With Inpatient ICI Therapy
Inpatient treatment with immune checkpoint inhibitors is associated with poor survival outcomes in patients with advanced cancer.
Improving the Rate of Serious Illness Conversations at Oncology Clinics
Researchers sought to increase the rate of serious illness conversations between clinicians and patients with cancer.
Active Surveillance Feasible for Low-Risk Thyroid Cancer
Active surveillance may be a viable management strategy for most diagnosed thyroid cancers, according to researchers.
Retevmo Approved for RET-Driven Solid Tumors, NSCLC
The approvals were based on data from the LIBRETTO-001 trial.
Donafenib May Be Alternative for Progressive, Advanced RAIR-DTC
Donafenib demonstrated efficacy in patients with progressive, locally advanced or metastatic radioactive iodine-refractory differentiated thyroid cancer.
Neoadjuvant Pembrolizumab Not Tied to More AEs in Oral Cavity SCC
Neoadjuvant pembrolizumab does not appear to increase rates of postoperative adverse events in patients with advanced head and neck cancer.
Adding Pembrolizumab to CRT Does Not Improve Outcomes in Head and Neck Cancer
Adding pembrolizumab to chemoradiotherapy did not improve event-free survival or overall survival.
Chronic Kidney Disease Is a Cancer Risk Factor, Study Finds
Cancer developed in 22% of patients diagnosed with chronic kidney disease at ages 50 to 80 years, which is higher than the lifetime risk of cancer in the general population, according to investigators.
Transoral Robotic Surgery Produces “Favorable” Outcomes in Head and Neck Cancer
At 5 years, the rate of local control was 62.2%, and the overall survival rate was 49.8%.
Immune Checkpoint Inhibitor Therapy Linked With Improved Quality of Life
Immune checkpoint inhibitor therapy appears to maintain or improve quality of life in patients with solid tumor malignancies.
Aggregating Data for Asian and Pacific Islander Patients May Mask Disparities
Grouping Asian and Pacific Islander patients together may hide disparities in cancer outcomes between these groups, according to researchers.
Men Have Higher Risk of Cancer; Demographic and Lifestyle Factors Don’t Explain It
Men tend to have a higher risk of cancer than women, and factors such as smoking, alcohol use, and diet do not appear to explain this disparity.
Cancer Patients With HIV May Not Receive Equitable Treatment
Cancer patients with HIV do not receive curative or palliative care in the same way as their HIV-negative peers.
Early Changes in ctDNA May Predict Treatment Outcomes in Advanced Cancer
Detection of ctDNA and early changes in ctDNA levels may predict treatment outcomes in patients with advanced solid tumors.
Thyroid Cancer Often Detected in Asymptomatic Patients
Many thyroid cancers are discovered in patients who undergo surgery without thyroid-referable symptoms, an international study suggests.
- Loading...
Loading...
Want to read more?
Please login or register first to view this content.
Loading... 
Loading...